FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
![Image that depicts and asortment of pills on the left, and a headline that reads "New Drug Therapy Approvals 2022."](https://public4.pagefreezer.com:443/content/FDA/22-02-2023T10:21/https://www.fda.gov/files/styles/medium_3/public/2022%20New%20Drugs_1600x900.png?itok=fzK4_K1F)
FDA Approved Many New Drugs in 2022 That Will Improve the Lives of Patients and Consumers
In 2022, CDER approved 37 new drugs never before approved or marketed in the U.S., known as “novel” drugs.
![Illustration of leader speaking to Colleagues with cover of Leadership Modernization Action Plan (LMAP) report on left side.](https://public4.pagefreezer.com:443/content/FDA/22-02-2023T10:21/https://www.fda.gov/files/styles/medium_3/public/LMAP_1600x900.png?itok=wnOUW14I)
Office of Digital Transformation’s New Focus on Technology Leadership
LMAP lays out our plans to strengthen our technology leadership capabilities to drive change at the business, technology, data, and cybersecurity levels.
Some table information
Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
---|